4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001641172-25-006555
CEO and CFO bought 3,600 shares at $9.88 ($35,568)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2025-04-25 | Purchase | +3,600 | $9.88 | $35,568 | 5,570,602 | D |
| Open-market purchases · 3,600 sh · avg $9.88 · $35,568 | |||||||
Loading xslF345X05/ownership.xml…